Insider Transactions in Q1 2023 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
492
+15.69%
|
-
|
|
Mar 31
2023
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
492
+0.01%
|
-
|
|
Mar 31
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
800
+14.9%
|
-
|
|
Mar 31
2023
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,138
+50.0%
|
-
|
|
Mar 31
2023
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
738
+1.87%
|
-
|
|
Mar 31
2023
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
492
+0.65%
|
-
|
|
Mar 31
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,108
+0.11%
|
-
|
|
Mar 14
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,293
-1.41%
|
$23,274
$18.73 P/Share
|
|
Mar 14
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,768
-6.53%
|
$31,824
$18.73 P/Share
|
|
Mar 14
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,768
-5.79%
|
$31,824
$18.73 P/Share
|
|
Mar 14
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,061
-5.96%
|
$19,098
$18.73 P/Share
|
|
Mar 14
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,061
-5.41%
|
$19,098
$18.73 P/Share
|
|
Jan 31
2023
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
533
+1.44%
|
-
|
|
Jan 31
2023
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
533
-100.0%
|
-
|
|
Jan 05
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
33,756
+26.84%
|
$0
$0.93 P/Share
|